摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-cyano-6-mercapto-4-methyl-2(1H)-pyridinone | 93272-85-6

中文名称
——
中文别名
——
英文名称
5-cyano-6-mercapto-4-methyl-2(1H)-pyridinone
英文别名
2-mercapto-4-methyl-6-oxo-1,6-dihydropyridine-3-carbonitrile;1,6-dihydro-2-mercapto-4-methyl-6-oxopyridine-3-carbonitrile;4-methyl-6-oxo-2-sulfanyl-1H-pyridine-3-carbonitrile
5-cyano-6-mercapto-4-methyl-2(1H)-pyridinone化学式
CAS
93272-85-6
化学式
C7H6N2OS
mdl
MFCD06652478
分子量
166.203
InChiKey
QNEWVOYCROIYKG-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    270-271 °C (decomp)
  • 沸点:
    314.7±42.0 °C(Predicted)
  • 密度:
    1.32±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    -0.1
  • 重原子数:
    11
  • 可旋转键数:
    0
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.142
  • 拓扑面积:
    53.9
  • 氢给体数:
    2
  • 氢受体数:
    3

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量
    • 1
    • 2

反应信息

  • 作为反应物:
    描述:
    5-cyano-6-mercapto-4-methyl-2(1H)-pyridinonelithium hydroxide monohydrate 、 potassium hydroxide 作用下, 以 四氢呋喃甲醇N,N-二甲基甲酰胺 为溶剂, 反应 4.0h, 生成 3-(((3-cyano-4-methyl-6-oxo-1,6-dihydropyridin-2-yl)thio)methyl)benzoic acid
    参考文献:
    名称:
    [EN] OXOPYRIDINE DERIVATIVES USEFUL AS AMINOCARBOXYMUCONATE SEMIALDEHYDE DECARBOXYLASE (ACMSD) INHIBITORS
    [FR] DÉRIVÉS D'OXOPYRIDINE UTILES EN TANT QU'INHIBITEURS DE LA SEMIALDÉHYDE DÉCARBOXYLASE D'AMINOCARBOXYMUCONATE (ACMSD)
    摘要:
    公开号:
    WO2018125983A8
  • 作为产物:
    描述:
    morpholinium 3-cyano-4-methyl-6-oxo-1,6-dihydropyridine-2-thiolate 在 盐酸 作用下, 以 为溶剂, 以6.83 g的产率得到5-cyano-6-mercapto-4-methyl-2(1H)-pyridinone
    参考文献:
    名称:
    Structure–Activity Relationships of Privileged Structures Lead to the Discovery of Novel Biased Ligands at the Dopamine D2 Receptor
    摘要:
    Biased agonism at GPCRs highlights the potential for the discovery and design of pathway-selective ligands and may confer therapeutic advantages to ligands targeting the dopamine D-2 receptor (D2R). We investigated the determinants of efficacy, affinity, and bias for three privileged structures for the D2R, exploring changes to linker length and incorporation of a heterocyclic unit. Profiling the compounds in two signaling assays (cAMP and pERK1/2) allowed us to identify and quantify determinants of biased agonism at the D2R. Substitution on the phenylpiperazine privileged structures (2-methoxy vs 2,3-dichloro) influenced bias when the thienopyridine heterocycle was absent. Upon inclusion of the thienopyridine unit, the substitution pattern (4,6-dimethyl vs 5-chloro-6-methoxy-4-methyl) had a significant effect on bias that overruled the effect of the phenylpiperazine substitution pattern. This latter observation could be reconciled with an extended binding mode for these compounds, whereby the interaction of the heterocycle with a secondary binding pocket may engender bias.
    DOI:
    10.1021/jm500457x
点击查看最新优质反应信息

文献信息

  • 4-(3-Cyanopyridin-2-ylthio)acetoacetates in synthesis of heterocycles
    作者:L. A. Rodinovskaya、A. M. Shestopalov、A. V. Gromova
    DOI:10.1023/b:rucb.0000011877.60574.34
    日期:2003.10
    Substituted 2-amino-4-aryl-3-cyano-5-oxo-5,6-dihydro-4H-pyrano[2,3-d]pyrido[3",2":4,5]thieno[3,2-b]pyridines were synthesized by the reactions of 4-hydroxy-1H-thieno[2,3-b;4,5-b]dipyridin-2-ones with arylidenemalononitriles or by the three-component reactions of hydroxythienodipyridinones with aldehydes and malononitrile in DMF in the presence of triethylamine. Methods for syntheses of substituted
    取代的 2-amino-4-aryl-3-cyano-5-oxo-5,6-dihydro-4H-pyrano[2,3-d]pyrido[3",2":4,5]thieno[3,2 -b]吡啶是通过 4-羟基-1H-噻吩并[2,3-b;4,5-b]二吡啶-2-与亚芳基丙二腈的反应或羟基噻吩吡啶与醛和丙二腈的三组分反应合成的在三乙胺存在下的 DMF 中。在4-(3-cyanopyridin-2-)反应的基础上,开发了取代3-烷基羰基-6-基-4-芳基-2-(3-氰基吡啶-2-基甲基)-4H-吡喃的合成方法。代)乙酰乙酸和亚芳基丙二腈或醛和丙二腈。4-(3-氰基吡啶-2-基基)乙酰乙酸乙酯4-甲氧基苄基代乙酰胺用于合成6-(吡啶-2-基甲基)-3-氰基吡啶-2(1H)-
  • The discovery of thienopyridine analogues as potent IκB kinase β inhibitors. Part II
    作者:Jiang-Ping Wu、Roman Fleck、Janice Brickwood、Alison Capolino、Katrina Catron、Zhidong Chen、Charles Cywin、Jonathan Emeigh、Melissa Foerst、John Ginn、Matt Hrapchak、Eugene Hickey、Ming-Hong Hao、Mohammed Kashem、Jun Li、Weimin Liu、Tina Morwick、Richard Nelson、Daniel Marshall、Leslie Martin、Peter Nemoto、Ian Potocki、Michel Liuzzi、Gregory W. Peet、Erika Scouten、David Stefany、Michael Turner、Steve Weldon、Clare Zimmitti、Denise Spero、Terence A. Kelly
    DOI:10.1016/j.bmcl.2009.08.054
    日期:2009.10
    An SAR study that identified a series of thienopyridine-based potent I kappa B Kinase beta (IKK beta) inhibitors is described. With focuses on the structural optimization at C(4) and C(6) of structure 1 (Fig. 1), the study reveals that small alkyl and certain aromatic groups are preferred at C(4), whereas polar groups with proper orientation at C(6) efficiently enhance compound potency. The most potent analogues inhibit IKKb with IC(50)s as low as 40 nM, suppress LPS-induced TNF-alpha production in vitro and in vivo, display good kinase selectivity profiles, and are active in a HeLa cell NF-kappa B reporter gene assay, demonstrating that they directly interfere with the NF-kappa B signaling pathway. (C) 2009 Elsevier Ltd. All rights reserved.
  • Dyachenko, V. D.; Sharanin, Yu. A.; Shestopalov, A. M., Journal of general chemistry of the USSR, 1990, vol. 60, # 10, p. 2131 - 2138
    作者:Dyachenko, V. D.、Sharanin, Yu. A.、Shestopalov, A. M.、Rodinovskaya, L. A.、Turov, A. V.、et al.
    DOI:——
    日期:——
  • Wagner; Vieweg; Leistner, Pharmazie, 1990, vol. 45, # 2, p. 102 - 109
    作者:Wagner、Vieweg、Leistner、Bohm、Krasselt、Hanfe ld、Prantz、Grupe
    DOI:——
    日期:——
  • New method of synthesis of substituted 2-pyridones
    作者:V. P. Litvinov、Yu. A. Sharanin、B. K. Promonenkov、L. A. Rodinovskaya、A. M. Shestopalov、V. Yu. Mortikov
    DOI:10.1007/bf00959212
    日期:1984.8
查看更多

同类化合物

(S)-氨氯地平-d4 (R,S)-可替宁N-氧化物-甲基-d3 (R)-(+)-2,2'',6,6''-四甲氧基-4,4''-双(二苯基膦基)-3,3''-联吡啶(1,5-环辛二烯)铑(I)四氟硼酸盐 (R)-N'-亚硝基尼古丁 (R)-DRF053二盐酸盐 (5E)-5-[(2,5-二甲基-1-吡啶-3-基-吡咯-3-基)亚甲基]-2-亚磺酰基-1,3-噻唑烷-4-酮 (5-溴-3-吡啶基)[4-(1-吡咯烷基)-1-哌啶基]甲酮 (5-氨基-6-氰基-7-甲基[1,2]噻唑并[4,5-b]吡啶-3-甲酰胺) (2S,2'S)-(-)-[N,N'-双(2-吡啶基甲基]-2,2'-联吡咯烷双(乙腈)铁(II)六氟锑酸盐 (2S)-2-[[[9-丙-2-基-6-[(4-吡啶-2-基苯基)甲基氨基]嘌呤-2-基]氨基]丁-1-醇 (2R,2''R)-(+)-[N,N''-双(2-吡啶基甲基)]-2,2''-联吡咯烷四盐酸盐 (1'R,2'S)-尼古丁1,1'-Di-N-氧化物 黄色素-37 麦斯明-D4 麦司明 麝香吡啶 鲁非罗尼 鲁卡他胺 高氯酸N-甲基甲基吡啶正离子 高氯酸,吡啶 高奎宁酸 马来酸溴苯那敏 马来酸氯苯那敏-D6 马来酸左氨氯地平 顺式-双(异硫氰基)(2,2'-联吡啶基-4,4'-二羧基)(4,4'-二-壬基-2'-联吡啶基)钌(II) 顺式-二氯二(4-氯吡啶)铂 顺式-二(2,2'-联吡啶)二氯铬氯化物 顺式-1-(4-甲氧基苄基)-3-羟基-5-(3-吡啶)-2-吡咯烷酮 顺-双(2,2-二吡啶)二氯化钌(II) 水合物 顺-双(2,2'-二吡啶基)二氯化钌(II)二水合物 顺-二氯二(吡啶)铂(II) 顺-二(2,2'-联吡啶)二氯化钌(II)二水合物 韦德伊斯试剂 非那吡啶 非洛地平杂质C 非洛地平 非戈替尼 非布索坦杂质66 非尼拉朵 非尼拉敏 雷索替丁 阿雷地平 阿瑞洛莫 阿扎那韦中间体 阿培利司N-6 阿伐曲波帕杂质40 间硝苯地平 间-硝苯地平 镉,二碘四(4-甲基吡啶)- 锌,二溴二[4-吡啶羧硫代酸(2-吡啶基亚甲基)酰肼]-